Australian industry disappointed as govt snubs stability deal
This article was originally published in Scrip
Executive Summary
Medicines Australia has expressed its disappointment at the health minister's decision not to sign a strategic agreement that would have provided the Australian industry with some policy stability over the next five years in return for agreeing to support medicines access and sustainability measures including price cuts to medicines listed on the Pharmaceutical Benefits Scheme.